Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Binley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gene Therapy|October 12, 1999
An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancerK Binley, S Iqball, A Kingsman, et al.
Gene Therapy|March 21, 2003
Hypoxia-mediated tumour targetingK Binley, Z Askham, L Martin, et al.
Human Gene Therapy|September 25, 1999
Characterization of physiologically regulated vectors for the treatment of ischemic diseaseK Boast, K Binley, S Iqball, et al.
Gene Therapy|May 31, 2003
Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularizationJ W B Bainbridge, A Mistry, K Binley, et al.
Gene Therapy|March 1, 2000
The macrophage - a novel system to deliver gene therapy to pathological hypoxiaL Griffiths, K Binley, S Iqball, et al.
The Journal of Gene Medicine|November 22, 2005
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectorsK S Balaggan, K Binley, M Esapa, et al.
Gene Therapy|May 9, 2008
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyJ Kong, S-R Kim, K Binley, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gene Therapy|October 12, 1999
An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancerK Binley, S Iqball, A Kingsman, et al.
Gene Therapy|March 21, 2003
Hypoxia-mediated tumour targetingK Binley, Z Askham, L Martin, et al.
Human Gene Therapy|September 25, 1999
Characterization of physiologically regulated vectors for the treatment of ischemic diseaseK Boast, K Binley, S Iqball, et al.
Gene Therapy|May 31, 2003
Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularizationJ W B Bainbridge, A Mistry, K Binley, et al.
Gene Therapy|March 1, 2000
The macrophage - a novel system to deliver gene therapy to pathological hypoxiaL Griffiths, K Binley, S Iqball, et al.
The Journal of Gene Medicine|November 22, 2005
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectorsK S Balaggan, K Binley, M Esapa, et al.
Gene Therapy|May 9, 2008
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyJ Kong, S-R Kim, K Binley, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Pageof 1